PEN
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSPenumbra, Inc. Common Stock (PEN) [ST]
www.penumbrainc.com ↗▲ 0.18%
prev close
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
-1
0 buys · 1 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-07-10 | PENPenumbra, Inc. Common Stock | Sell | $1,001 - $15,000 | 232d ago | — |
2025-07-10
Lisa McClain
PEN
Amount
$1,001 - $15,000
Filed
232d ago
Recent News
Powered by Polygon.io
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages
Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-07-10 · Sale
$1,001 - $15,000